159 related articles for article (PubMed ID: 24752961)
1. Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?).
Tabibian JH; Lindor KD
Hepatology; 2014 Sep; 60(3):785-8. PubMed ID: 24752961
[No Abstract] [Full Text] [Related]
2. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.
Wunsch E; Trottier J; Milkiewicz M; Raszeja-Wyszomirska J; Hirschfield GM; Barbier O; Milkiewicz P
Hepatology; 2014 Sep; 60(3):931-40. PubMed ID: 24519384
[TBL] [Abstract][Full Text] [Related]
3. Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis.
Santander C; Moreno-Otero R
Aliment Pharmacol Ther; 2012 Apr; 35(7):846; discussion 847. PubMed ID: 22404405
[No Abstract] [Full Text] [Related]
4. Medical therapy for primary sclerosing cholangitis.
Wong GL; Wong VW
Aliment Pharmacol Ther; 2011 Nov; 34(9):1135-6; discussion 1136-7. PubMed ID: 21981734
[No Abstract] [Full Text] [Related]
5. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
Olsson R; Boberg KM; de Muckadell OS; Lindgren S; Hultcrantz R; Folvik G; Bell H; Gangsøy-Kristiansen M; Matre J; Rydning A; Wikman O; Danielsson A; Sandberg-Gertzén H; Ung KA; Eriksson A; Lööf L; Prytz H; Marschall HU; Broomé U
Gastroenterology; 2005 Nov; 129(5):1464-72. PubMed ID: 16285948
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.
Chapman RW
Dig Liver Dis; 2003 May; 35(5):306-8. PubMed ID: 12846401
[No Abstract] [Full Text] [Related]
7. Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
Chapman RW
Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):74-5. PubMed ID: 20134486
[No Abstract] [Full Text] [Related]
8. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.
Sinakos E; Marschall HU; Kowdley KV; Befeler A; Keach J; Lindor K
Hepatology; 2010 Jul; 52(1):197-203. PubMed ID: 20564380
[TBL] [Abstract][Full Text] [Related]
9. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
[No Abstract] [Full Text] [Related]
10. Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.
Assis DN; Abdelghany O; Cai SY; Gossard AA; Eaton JE; Keach JC; Deng Y; Setchell KD; Ciarleglio M; Lindor KD; Boyer JL
J Clin Gastroenterol; 2017 Feb; 51(2):e11-e16. PubMed ID: 27428727
[TBL] [Abstract][Full Text] [Related]
11. Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey.
Okolicsanyi L; Groppo M; Floreani A; Morselli-Labate AM; Rusticali AG; Battocchia A; Colombo M; Galatola G; Gasbarrini G; Podda M; Ricci G; Rosina F; Zuin M
Dig Liver Dis; 2003 May; 35(5):325-31. PubMed ID: 12846404
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
Triantos CK; Koukias NM; Nikolopoulou VN; Burroughs AK
Aliment Pharmacol Ther; 2011 Oct; 34(8):901-10. PubMed ID: 21883323
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis and bile acids.
Chazouillères O
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S21-5. PubMed ID: 23141889
[TBL] [Abstract][Full Text] [Related]
14. Treatment of primary sclerosing cholangitis.
Floreani A; De Martin S
Dig Liver Dis; 2021 Dec; 53(12):1531-1538. PubMed ID: 34011480
[TBL] [Abstract][Full Text] [Related]
15. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
[TBL] [Abstract][Full Text] [Related]
17. Ulcerative colitis and an abnormal cholangiogram.
Nguyen DL; Lazaridis KN
Cleve Clin J Med; 2011 May; 78(5):306-11. PubMed ID: 21536825
[No Abstract] [Full Text] [Related]
18. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
19. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
Serfaty L; Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
[No Abstract] [Full Text] [Related]
20. Ursodeoxycholic acid in primary sclerosing cholangitis.
Triantos CK; Koukias N; Nikolopoulou V; Burroughs AK
Aliment Pharmacol Ther; 2012 Mar; 35(5):622-3. PubMed ID: 22300127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
